Invion

Invion is a life sciences company focussed on the development of treatments for major opportunities in chronic inflammatory and autoimmune diseases. The Group has a number of drug assets under development or for partnering. Invion is an ASX listed company (ASX:IVX), with operations in Melbourne, Australia and Delaware, USA.